Chemomab Therapeutics Ltd. (CMMB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$609.0K2018: $9.80M2019: $12.37M2020: $10.80M2021: $61.47M2022: $36.22M2023: $17.00M2024: $13.54M2025: $12.33M$12.33M
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$12.33M-8.9%
2024$13.54M-20.4%
2023$17.00M-53.1%
2022$36.22M-41.1%
2021$61.47M+469.0%
2020$10.80M-12.7%
2019$12.37M+26.2%
2018$9.80M+1710.0%
2017-$609.0K